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EDITORIAL
On the publication of the results of X-ray crystal structure analysis in
Metal-Based Drugs
The importance of single crystal structure analysis employing X-ray diffraction methods is
undisputed in chemistry/biochemistry. With the advent of area-detector diffractometers and
increased automation, it may be anticipated that more structures will be determined and published
than previously. The purpose of this Editorial is to set some general guidelines for the publication
of crystallographic results in Metal-Based Drugs.
The guidelines annunciated below are not meant to circumvent the idea that in a paper ’sufficient
detail should be presented in order to allow others to repeat the experiment’. Rather, the
guidelines are specified in recognition that many X-ray crystal structure determinations are ’routine’
and thereby require no particular or special description of experimental procedures. Authors of
papers containing the results of crystal structure determinations are encouraged to check carefully
that their submissions match the guidelines below. Of course, deviations from these guidelines will
be allowed as long as a justification for the deviation is given.
Abstract: While it would be normal to mention that a crystal structure determination is reported, it
is not necessary to include crystallographic data in the Abstract.
Experimental: For many papers, the Experimental section will comprise a brief statement on how
the crystals were obtained and include a suitably modified Table based on the following template:
Table 1. Crystal data for
Formula
Crystal system
Space group
b,A
,/,
Z
Temperature, K
Trans. factors
F(000)
Reflns meas.
Reflns with/> no(/)
R(F or ), Rw(F or F)
Programs used
Deposition number CCDC XXXXXX
Formula weight
Crystal size, mm a,
c,,&,
v,A
Diffractometer
p(radiation used), cm
Dcalcd, g cm
"3
Reflns unique, Rint
Weighting scheme p,e"3
This Table reports the key experimental details for a crystal structure analysis and is sufficient for
publication of a structure in Metal-Based Drugs. Reformatting of the Table to accommodate papers
reporting more than one structure is preferable to the inclusion of two (or more) separate Tables.
Additional text should be included in the Experimental section when necessary. The additional text
could be a discussion of special procedures employed in the data collection and/or refinement,
treatment of disorder, location of large residual electron density peaks, details of absolute structure
determination, etc.
Each structure submitted to Metal-Based Drugs must have its crystallographic data (preferably in
CIF format) deposited at the Cambridge Crystallographic Data Centre and a CCDC deposition
number must be included in the Table. Supplementary Material (preferably in CIF format)
should still be submitted with manuscripts for the purposes of review. As the CCDC makes
available crystallographic data upon request [1], there is no need in normal circumstances to
publish fractional atomic coordinates.Discussion: The description of the structure should include a discussion of key and relevant
features of the molecular structure, and the relationship between the structure and other data such
as spectroscopic and biological results. It would be appropriate to place the structure in the context
of related studies.
A listing of salient interatomic parameters (e.g. phenyl C-C distances are not usually required)
should be included in tabular form or, in the case of limited data, in the caption to the Figure.
Each structure should be represented by a thermal ellipsoid plot and the probability level for the
displacement ellipsoids stated.
When appropriate, an analysis of intermolecular interactions should be included and in these
circumstances a unit cell diagram can be published if this enhances the description of the crystal
structure.
[1] Copies of data deposited at the CCDC may be obtained free of charge from The Director,
CCDC, 12 Union Road, Cambridge CB2 1EZ, England (Facsimile: 44-1223-336033 or e-mail:
deposit@ccdc.cam .ac.uk).
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